|
HS Code |
628849 |
| Generic Name | Broxuridine |
| Synonyms | Bromodeoxyuridine, BrdU |
| Formula | C9H11BrN2O5 |
| Molecular Weight | 307.1 g/mol |
| Drug Class | Antiviral, antineoplastic agent |
| Cas Number | 62-59-9 |
| Appearance | White to off-white crystalline powder |
| Route Of Administration | Topical, ophthalmic |
| Mechanism Of Action | Inhibits viral DNA synthesis by incorporation into DNA |
| Indications | Herpes simplex keratitis |
| Storage Conditions | Store at room temperature, away from light and moisture |
| Brand Names | Ulvadine, Broxine |
As an accredited Broxuridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Broxuridine is provided in a 1 gram amber glass vial, featuring a tamper-evident seal and clearly labeled with handling instructions. |
| Shipping | Broxuridine is shipped in secure, tightly sealed containers to prevent contamination and degradation. It is typically transported at controlled room temperature unless otherwise specified. Proper labeling and documentation, in compliance with regulatory guidelines for hazardous chemicals, are included to ensure safe handling during transit and delivery to laboratories or licensed facilities. |
| Storage | Broxuridine should be stored in a tightly closed container at 2–8°C (refrigerated), protected from light and moisture. Keep it in a well-ventilated, dry area away from incompatible substances such as strong oxidizers and acids. Ensure it is clearly labeled and accessible only to trained personnel, following all relevant safety and regulatory guidelines for hazardous chemicals. |
Applications of Broxuridine in Industrial ManufacturingBroxuridine, as a synthetic nucleoside analogue, plays a critical role in several downstream industrial segments due to its unique chemical properties and established regulatory profile. With decades of performance data in controlled environments, this material has proven reliable in enabling precise molecular modifications in industrial biotechnology, guided by strict compliance and consistent product specifications. Below, we detail the principal real-world application scenarios where Broxuridine serves as an integral formulation component. 1. Antiviral Raw Material for Active Pharmaceutical Ingredient (API) SynthesisBroxuridine is widely used in the pharmaceutical sector as a foundational building block for the synthesis of antiviral APIs, particularly for topical formulations targeting herpes simplex keratitis. Its well-characterized interaction with viral DNA polymerase makes it an essential intermediate in the manufacture of certain nucleoside analogues, supporting predictable pharmacokinetics and well-established dosage form development pathways. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Research-Grade Radiolabeling Agent for DNA Synthesis StudiesLaboratory-scale DNA synthesis research frequently employs Broxuridine as a radiolabeling precursor. Its structural similarity to thymidine allows for precise tracking of DNA replication and cell proliferation in controlled studies. This application is well-documented in research supply chain management, supporting clinical and molecular biology laboratories focused on quantifying DNA synthesis rates in eukaryotic cells. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Diagnostic Reference Material for DNA Replication MarkersBroxuridine functions as a reference standard in in vitro diagnostic (IVD) kit production, particularly for monitoring DNA replication markers in hematology and oncology workflows. Its predictable chemical behavior enables calibration of detection systems such as flow cytometry and immunohistochemistry platforms, where quantitative accuracy in S-phase cell detection is paramount to diagnostic output quality. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Ancillary Component in Cytostatics Manufacturing WorkflowAs an ancillary compound, Broxuridine is used during the early stages of cytostatic drug research and pilot manufacturing to screen nucleoside analog candidates for cytotoxicity profiles against malignant cell lines. In this capacity, it supports high-throughput screening platforms and contributes benchmark data for structure-activity relationship (SAR) studies, which guide further development of cytostatics with defined toxicity and selectivity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Broxuridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in chemical manufacturing teaches the importance of consistency, transparency, and real work behind each batch. Broxuridine belongs to a group of specialized raw materials that have supported numerous critical processes across pharmaceutical research and development. Over the last decade, we have observed Broxuridine’s influence grow stronger, especially among teams working on antiviral agents and DNA labeling projects. The lessons learned from days spent checking the color clarity, moisture content, and particle size have helped us refine this compound, making it a dependable part of our production line.
Broxuridine, chemically known as 5-bromo-2'-deoxyuridine, comes from a process that prioritizes raw input traceability. Unlike generic offerings that drift from batch to batch, we have found tight control over synthesis parameters results in higher reproducibility. Our model ships in a fine powder form, white to off-white, with a purity level exceeding 99 percent based on HPLC and NMR verification. Every pack comes sealed with a lot number linked to individual analytical results. The absence of unexpected by-products or discoloration speaks volumes for operators relying on a controlled reaction environment.
From a manufacturing standpoint, specifications matter. Years of collaboration with process chemists and formulation scientists shaped our particle size range, deliberately matching what most laboratory and pilot-scale users prefer. Moisture content sometimes makes a difference when Broxuridine interacts with solvents, so we have adjusted our drying and packaging methods to keep it below established tolerance levels. Our scale-up experience highlights small things, such as handling flow, clumping under storage, and ease of weighing, because impatience on the shop floor can undo hours of careful preparation.
Broxuridine is not manufactured for novelty or shelf decoration. In our facility, its primary route of use supports DNA labeling, replication studies, and preclinical research. Scientists select Broxuridine for its ability to substitute for thymidine in nucleic acids, introducing a marker that modern immunocytochemistry can pick out. This property opens the door to a detailed examination of cell proliferation and DNA synthesis. From conversations with research partners, we see Broxuridine’s role in guiding studies that seek to understand cancer cell activity or viral mechanics.
During trials and scale-up campaigns, concentration tolerance and solubility surfaced as common topics. Some researchers used Broxuridine as an antiviral, working to disrupt replication machinery. A consistent complaint from early users involved variability between batches coming from different suppliers. By documenting our conditions and keeping closer attention to each batch, we offer certainty where others leave open guesswork. Our team keeps records from raw material procurement through the final drying stage, so repeat performance is not a gamble.
Those who run in vitro work rely on predictable dissolution and straightforward handling. By consulting regularly with end-users, we introduced standardized packaging formats. Larger laboratories prefer bulk options stored in opaque, robust containers, while groups working on sensitive runs often prefer smaller aliquots to reduce the risk of cross-contamination and waste. This flexibility stems from our understanding of how products move through real laboratory environments.
Competition in nucleoside analogs runs deep, yet Broxuridine stands out once one looks beyond numbers on a specification sheet. Unlike analogs such as EdU or BrdU, Broxuridine exhibits a gentle interaction profile with cellular enzymatic machinery, which researchers appreciate during long-term culture experiments. EdU, for example, introduces click-chemistry capabilities, but several partners reported background toxicity that skews outcomes in delicate primary cells. Broxuridine strikes a balance between specificity and manageable side effects. By talking face-to-face with cellular biologists and molecular researchers, our manufacturing team learned that switching analogs mid-experiment wastes time and budget, so we focused on producing Broxuridine with batch-to-batch reliability.
Stability and storage shelf life have real-world consequences, especially in climates with high humidity. Our formulation includes desiccant packs and UV-resistant packaging to maintain activity. Others sometimes skip these steps to cut costs, but we have seen first-hand the frustration that comes from a spoiled shipment. In comparisons performed by several independent laboratories, our Broxuridine resisted hydrolysis over longer periods than most competing brands under similar storage conditions.
Product differences run deeper than outward appearance. Some Broxuridine on the market comes with trace organic solvents or unidentified particulate matter. By refusing to compromise during purification and adopting in-house filtration steps, our batches meet tighter targets. As the people making what ends up in your centrifuge tubes, we understand shaving a percent off impurity saves research groups months of troubleshooting.
Years spent preparing and testing Broxuridine taught the value of precise documentation. Every lot receives a full certificate of analysis, featuring up-to-date data on assay value, moisture, melting point, and residual solvents. For teams requiring extra certainty, we provide access to chromatograms and NMR spectra—real data, not generic claims. Researchers trust supplies that trace all the way back to the raw source, and we respond with open access to our process records when needed.
Operators running cytotoxicity screens or precise radiolabeling experiments reached out to us in the past after inconsistent results from poorly documented analogs. By embedding rigorous tracking and allowing questions at every shipment stage, we save experts hours of revalidation. Our internal auditors double-check storage logs, cleaning history, and environmental controls—practices born from learning what it takes to maintain a high degree of analytical consistency over a decade of production.
We do not chase volume over quality. Each batch goes through tests for residual solvents (GC), heavy metals (ICP-MS), and microbial contamination. Fielding calls from quality assurance officers gave us a sense of how minor lapses snowball in regulated environments. Without these steps, Broxuridine would never earn a place on the benches of respected labs.
Manufacturing Broxuridine offers a front-row seat to the roll-out of new scientific ideas. Research collaborators, contract testing facilities, and pharmaceutical partners keep our team sharp and honest. In the past, supply chain interruptions forced us to rethink local sourcing and implement dual-vendor controls for key inputs. As a manufacturer, the lesson is clear: research timelines do not wait on logistical excuses, so backup systems matter. We keep raw material buffers and service agreements with local truck lines to minimize delivery delays, especially during periods of high demand in influenza or coronavirus research.
From a manufacturer’s perspective, product quality grows from friendships and feedback, not one-way transactions. Process engineers, packaging line workers, and lab scientists gather after shipments to review customer comments. Several improvements in dust control, anti-static linings, and custom packaging arose from real users who shared problems in their workflow. We do not see products as finished once they leave our dock. Follow-through drives long-term success.
Some government-funded projects require documentation on Good Manufacturing Practice (GMP) compliance. We offer both standard research-grade and select GMP-certified variants. Maintaining a dedicated area for GMP processing adds to operating costs, yet we have seen grant-funded researchers gain an edge when they can prove traceability and regulatory compliance from day one. This hands-on approach helps research organizations compete and pass audits from regulatory authorities.
Chemicals such as Broxuridine sell not just on sticker price but on the strength of the support behind them. Discounts that shave pennies sometimes introduce headaches of out-of-spec material, missed deadlines, and repeated troubleshooting. Our approach leans into transparency; price quotes arrive with realistic lead times, and our published inventory matches warehouse holdings. Our inventory system, built in-house, allows instant look-up of expiration dates and storage status, so promises given over the phone carry weight.
Reliable supply means more than shipping boxes. Broxuridine must survive temperature shifts, customs holds, and long-term storage in customer freezers. Our logistics team lines each box with validated cold-chain insulation for shipments heading into regions with extreme climates. Returns and replacements form a tiny part of our turnover—scrutinizing temperature logs and real-time location tags taught us how to prevent spoilage before it starts.
The real cost of chemical interruptions shows up in missed grant deadlines or wasted assays. Researchers often recount stories of projects that delayed costly clinical or preclinical runs due to substandard supply. Years spent in chemical manufacturing create an awareness that supporting researchers at the bench can tip the scales in drug discovery timelines. We do not overextend production to chase spot-market orders. Brokers sometimes offer surge pricing after shortages, but the investments we make in raw material storage keep our partners insulated from most spikes.
Our production staff answers detailed questions about solution preparation, recommended storage temperatures, and unusual analytical findings. We keep a technical support team on hand, composed mostly of colleagues who spent years on the production floor. They offer advice on solubility, handling, and contamination risks because they learned what matters after handling hundreds of batches.
From time to time, new applications emerge. Research groups occasionally find Broxuridine supports novel in vivo labeling protocols or can unlock new cell tracing techniques. We run limited pilot productions for innovative applications. Researchers can request small-scale test batches with tailored specifications—our flexibility reflects our commitment to supporting ongoing discovery rather than limiting customers to a fixed catalog. We relish feedback, both positive and critical, and log user insights to inform the next run.
Beyond the bench, safety remains central. Our safety data sheets reflect lessons learned after handling diverse hazards in a working plant. Proper PPE, local exhaust, and efficient cleanup protocols come from real training. We offer hands-on guidance during onboarding or product trials for new teams joining our research partner network.
Chemicals that matter for research evolve with the landscape. Sustainability has moved from buzzword to necessity in our operations. Waste management, energy recovery, and solvent recycling form part of the daily routine in our plant. Broxuridine production, with its reliance on halogenation and sensitive crystallization, creates a responsibility to minimize environmental burden. When regulations evolve or greener chemistry opens a new pathway, we adapt quickly. Our engineers run ongoing assessments to squeeze down process waste, and we report results to stakeholders through published audits.
Suppliers working close to the source control the safety and environmental impact of their output in ways distant brokers cannot. Local partnerships create shorter, more reliable supply chains and less packaging waste. During plant upgrades, we prioritized closed-loop solvent systems, modern instrumentation, and energy-efficient temperature controls. These investments cut emissions and secure long-term viability.
End-users asked for biodegradable packaging and less-hazardous shipping labels. While balancing regulations with safety needs, we shifted packaging to recycled materials and simplified container formats. Each shift, we solicit feedback to confirm that adjustments increase convenience without sacrificing shelf life or stability.
Years of hands-on manufacturing, regular customer contact, and process improvements shaped Broxuridine into a product teams can trust during research campaigns. Consistency batch to batch comes not from slogans, but from the dedication of line workers, process chemists, and logistics staff who accept nothing less than the best possible product. Competition and innovation drive us to continue refining what we offer, not just to meet published standards, but to exceed them wherever experience and feedback point the way.
Broxuridine’s importance stretches far beyond its chemical structure. End users see smoother experiments, clearer results, and fewer costly interruptions. As a manufacturer, we see each order as part of an ongoing partnership — delivering not just a box of chemical, but a piece of the broader puzzle in scientific discovery. We look forward to keeping Broxuridine a reliable fixture on benches, in freezers, and in breakthroughs for many years.